Kinnate Biopharma OverviewKinnate Biopharma Other Income Expense Net
Other Income/Expense Net for KNTE.
Quarterly Other Income/Expense
$2.05M
↑ 82.52% YoY
As of Dec 31, 2023
Annual Other Income/Expense (TTM)
$8.33M
↑ 270.31% YoY
Trailing 12 months ending Dec 31, 2023